G. Prasad

发表

Recent advances in experimental molecular therapeutics for malignant gliomas.

Hui Wang, Ruiwen Zhang, D. Hill, 2004, Current medicinal chemistry. Anti-cancer agents.

Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.

K. Matthay, M. Polley, A. Davidoff, 2011, Cancer letters.

Antisense anticancer oligonucleotide therapeutics.

J. Buolamwini, Hui Wang, H. Wang, 2001, Current cancer drug targets.

Antisense anti-MDM2 oligonucleotides as a novel approach to the treatment of glioblastoma multiforme.

Hui Wang, S. Agrawal, Ruiwen Zhang, 2002, Anticancer research.

Determination of desoxyepothilone B in nude mice plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.

Hui Wang, Ruiwen Zhang, L. Nan, 2006, Journal of pharmaceutical and biomedical analysis.

Radiosensitization by Antisense Anti-MDM2 Mixed-Backbone Oligonucleotide in in Vitro and in Vivo Human Cancer Models

Hui Wang, Dong Yu, S. Agrawal, 2004, Clinical Cancer Research.

Tissues Harvested Using an Automated Surgical Approach Confirm Molecular Heterogeneity of Glioblastoma and Enhance Specimen's Translational Research Value

N. Salomonis, L. Soroceanu, E. Zusman, 2019, Front. Oncol..

Inhibition of PI3K/mTOR pathways in glioblastoma and implications for combination therapy with temozolomide.

Mitchel S. Berger, William A. Weiss, Mei-Yin Polley, 2011, Neuro-oncology.

Outcomes Following Radiosurgery for the Treatment of Primary or Metastatic Intracranial Sarcomas

P. Sneed, M. McDermott, G. Prasad, 2008 .

Radiation-induced gliomas

D. Haas-Kogan, G. Prasad, 2009, Expert review of neurotherapeutics.